Literature DB >> 9774583

Molecular analysis of glycopeptide-resistant Enterococcus faecium isolates collected from Michigan hospitals over a 6-year period.

L Thal1, S Donabedian, B Robinson-Dunn, J W Chow, L Dembry, D B Clewell, D Alshab, M J Zervos.   

Abstract

The purpose of this study was to evaluate the molecular relatedness of clinical isolates of glycopeptide-resistant Enterococcus faecium isolates collected from hospitals in Michigan. A total of 379 isolates used in this study were all vancomycin-resistant E. faecium isolates collected from 28 hospitals and three extended-care facilities over a 6-year period from 1991 to 1996. For the 379 isolates, there were 73 pulsed-field gel electrophoresis (PFGE) strain types. Within strain types, there were as many as six restriction fragment differences. Most isolates (70%) belonged to six strain types, which were designated M1 (36%), M2 (3%), M3 (18%), M4 (6%), M10 (4%), and M11 (3%). PFGE strain M1 was cultured from 135 patients in 13 hospitals during the period 1993 to 1996. Strain type M2 was cultured from 11 patients in two hospitals during the period 1991 to 1992 and was not observed after 1992. Strain type M3 was cultured from 70 patients in 10 hospitals during the period of 1994 to 1996. Both M4 and M10 were cultured from 23 patients in three hospitals and from 15 patients in two hospitals, respectively, during 1995 to 1996. M11 was cultured from 13 patients in four hospitals during 1996. A total of 23 of 28 hospitals had evidence of clonal dissemination of some isolates. Plasmid content and hybridization analysis done on 103 isolates from one hospital and two affiliated extended-care facilities indicated that the strains contained from one to eight plasmids. Mating experiments indicated transfer of vancomycin resistance from 94 of these isolates into plasmid-free E. faecium GE-1 at transfer frequencies of <10(-9) to 10(-4). Gentamicin resistance and erythromycin resistance were cotransferred at various frequencies. A probe for the vanA gene hybridized to the plasmids of 23 isolates and to the chromosomes of 72 isolates. A probe for the vanB gene hybridized to the chromosomes of 8 isolates. The results of this study suggest inter- and intrahospital dissemination of vancomycin-resistant E. faecium strains over a 6-year period in southeastern Michigan. The majority of isolates studied belonged to the same few PFGE strains, indicating that clonal dissemination was responsible for most of the spread of resistance that occurred.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774583      PMCID: PMC105319     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

Review 1.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

2.  High-level resistance to aminoglycosides: comparison of community and nosocomial fecal isolates of enterococci.

Authors:  T M Coque; R C Arduino; B E Murray
Journal:  Clin Infect Dis       Date:  1995-04       Impact factor: 9.079

3.  Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States.

Authors:  S Handwerger; J Skoble; L F Discotto; M J Pucci
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

Review 4.  Genetics and mechanisms of glycopeptide resistance in enterococci.

Authors:  M Arthur; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

5.  Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers.

Authors:  H S Sader; M A Pfaller; F C Tenover; R J Hollis; R N Jones
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

6.  Emergence of vancomycin-resistant enterococci in New York City.

Authors:  T R Frieden; S S Munsiff; D E Low; B M Willey; G Williams; Y Faur; W Eisner; S Warren; B Kreiswirth
Journal:  Lancet       Date:  1993-07-10       Impact factor: 79.321

7.  Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin.

Authors:  S Handwerger; B Raucher; D Altarac; J Monka; S Marchione; K V Singh; B E Murray; J Wolff; B Walters
Journal:  Clin Infect Dis       Date:  1993-06       Impact factor: 9.079

8.  A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci.

Authors:  H S Gold; S Unal; E Cercenado; C Thauvin-Eliopoulos; G M Eliopoulos; C B Wennersten; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

9.  Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance.

Authors:  J M Boyce; S M Opal; J W Chow; M J Zervos; G Potter-Bynoe; C B Sherman; R L Romulo; S Fortna; A A Medeiros
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

10.  Characterization of glycopeptide-resistant enterococci from U.S. hospitals.

Authors:  N C Clark; R C Cooksey; B C Hill; J M Swenson; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

View more
  20 in total

1.  Large conjugative vanA plasmids in vancomycin-resistant Enterococcus faecium.

Authors:  G Werner; I Klare; W Witte
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci.

Authors:  R Kariyama; R Mitsuhata; J W Chow; D B Clewell; H Kumon
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

3.  Heteroresistance to vancomycin in Enterococcus faecium.

Authors:  M R Alam; S Donabedian; W Brown; J Gordon; J W Chow; M J Zervos; E Hershberger
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

4.  Multilocus variable-number tandem-repeat polymorphism among Brazilian Enterococcus faecalis strains.

Authors:  Ricardo Titze-de-Almeida; Rob J L Willems; Janetta Top; Isabela Pereira Rodrigues; Renato Fonseca Ferreira; Hélène Boelens; Maria Christina C Brandileone; Rosemeire C Zanella; Maria Sueli Soares Felipe; Alex van Belkum
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

5.  Outbreak of vancomycin-resistant Enterococcus faecium of the phenotype VanB in a hospital in Warsaw, Poland: probable transmission of the resistance determinants into an endemic vancomycin-susceptible strain.

Authors:  M Kawalec; M Gniadkowski; M Zaleska; T Ozorowski; L Konopka; W Hryniewicz
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

6.  Antibiotic Resistance of LACTOBACILLUS Strains.

Authors:  Elizaveta A Anisimova; Dina R Yarullina
Journal:  Curr Microbiol       Date:  2019-09-25       Impact factor: 2.188

7.  Clonal spread of a vancomycin-resistant Enterococcus faecium strain among bloodstream-infecting isolates in Italy.

Authors:  Lucia Stampone; Maria Del Grosso; Delia Boccia; Annalisa Pantosti
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

8.  Selection of a teicoplanin-resistant Enterococcus faecium mutant during an outbreak caused by vancomycin-resistant enterococci with the vanB phenotype.

Authors:  M Kawalec; M Gniadkowski; J Kedzierska; A Skotnicki; J Fiett; W Hryniewicz
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

9.  Possible connection between a widely disseminated conjugative gentamicin resistance (pMG1-like) plasmid and the emergence of vancomycin resistance in Enterococcus faecium.

Authors:  Haruyoshi Tomita; Carl Pierson; Suk Kyung Lim; Don B Clewell; Yasuyoshi Ike
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

10.  A functional collagen adhesin gene, acm, in clinical isolates of Enterococcus faecium correlates with the recent success of this emerging nosocomial pathogen.

Authors:  Sreedhar R Nallapareddy; Kavindra V Singh; Pablo C Okhuysen; Barbara E Murray
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.